The importance of prescriptomics and precision medicine in the 21st century is highlighted by the advancements in mass spectrometry, omics technologies, and artificial intelligence. Prescriptomics is an emerging field that focuses on the complex interplay of genetics, proteomics, transcriptomics, metabolomics and epigenetics, and their impact on the effectiveness, safety, and response to prescription medications and precision medicine. This approach goes beyond conventional methods, aiming for a transformative paradigm that enables the precise tailoring of treatment strategies. This leads to minimised adverse effects and optimised therapeutic outcomes, marking a significant shift towards personalized precise medicine

The 1st International Caparica Conference on Prescriptomics and Precision Medicine 2024, scheduled for May 2024 in Caparica, Portugal, is set to feature prominent experts in this field. Plenary speakers include Benedikt Brors from the German Cancer Research Center, Rong Fan from Yale School of Medicine, Anil Korkut from MD Anderson Cancer Center, and Forest White from MIT Center for Precision Cancer Medicine. Keynote speakers such as Nikos Tapinos from Brown University, Russel Rockne from the Beckman Research Institute of City of Hope, Yue Lu from The University of Utah, Albert Grinshpun from Hebrew University- Hadassah Medical School, Ritambhara Singh also from Brown University, and Alexander Xu from Cedars-Sinai Medical Center will also contribute their insights.

The conference will cover various subjects, including the utilization of omics technologies for diagnostic purposes, navigating sample collection and handling techniques, effective patient follow-up strategies, bioinformatics, leveraging AI in enhancing prescription accuracy, precision in prescription management, and insights into point of care devices. This event underscores the rapid evolution and significance of prescriptionomics and precision medicine in contemporary healthcare, emphasizing the role of cutting-edge technologies in advancing this field.

It is important to note that the conference is designed to be an exclusive event, with no more than 150 participants. This deliberate limitation in size ensures that only the pioneers in the field of prescriptomics and precision medicine are present. The goal is to create a focused and high-level environment conducive to fostering new collaborations and establishing teams that will lead future advancements in this groundbreaking area of medical research and practice. This approach underscores the conference’s commitment to driving forward the frontiers of precision medicine and prescriptomics.

We look forward to your comments.

Yours truly
J. L. Capelo

C. Lodeiro
Conference chairs
On behalf of the organizing and scientific committee

• Utilizing Omics Technologies for Diagnostic Purposes
• Navigating Through Sample Collection and Handling Techniques
• Strategies for Effective Patient Follow-Up
• Decoding Biological
• Data: An Exploration into Bioinformatics
• Leveraging Artificial Intelligence in Enhancing Prescription Accuracy
• Approaches to Precision in Prescription Management
• Innovation at Hand: An Insight into Point of Care Devices